In conclusion, our work identifies a role for DEF6 in regulating CTLA-4 availability and trafficking to prevent autoimmunity, in line with CTLA-4 functioning both as immune rheostat and defining thresholds of immune activation for anti-cancer immunity11,13,14,56. The gene discussed is CTLA4; the disease is cancer.